Literature DB >> 14977840

Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma.

Masahide Ikeguchi1, Ken-ichi Yamaguchi, Nobuaki Kaibara.   

Abstract

PURPOSE: Lymph node metastasis is the most important predictor of prognosis in esophageal squamous cell carcinoma (ESCC). Recently, KiSS-1 was cloned as a human metastasis suppressor gene, and an orphan G-protein-coupled receptor (hOT7T175) was identified as the endogenous receptor of the KiSS-1 product. However, the clinical importance of KiSS-1 and hOT7T175 gene expression in ESCC remains unclear. EXPERIMENTAL
DESIGN: In this study, total RNA was extracted from tumors and noncancerous epithelia of 71 patients with ESCC who underwent surgical esophageal resection. The expression levels of KiSS-1, hOT7T175, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNAs were analyzed quantitatively by real-time reverse transcription-PCR and compared with the clinical findings.
RESULTS: The mean KiSS-1:GAPDH and hOT7T175:GAPDH ratios of the tumors were 1.2 and 0.3 and were at the same levels as those in the noncancerous epithelia. The loss of KiSS-1 and hOT7T175 gene expression was detected in 38% and 61% of tumors. Loss of KiSS-1 and/or hOT7T175 gene expression was not correlated with tumor size or degree of tumor invasion but was found to be a significant predictor of lymph node metastasis.
CONCLUSIONS: Loss of KiSS-1 or hOT7T175 gene expression may be an important biomarker for detection of lymph node metastasis in ESCC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977840     DOI: 10.1158/1078-0432.ccr-1519-02

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  49 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  KiSS-1 expression in human breast cancer.

Authors:  Tracey A Martin; Gareth Watkins; Wen G Jiang
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Kisspeptin-54 levels are increased in patients with colorectal cancer.

Authors:  Emel Canbay; Arzu Ergen; Dursun Bugra; Sumer Yamaner; Ilhan Yaylim Eraltan; Yilmaz Buyukuncu; Turker Bulut
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

Review 4.  KISS1 in breast cancer progression and autophagy.

Authors:  Ilya V Ulasov; Anton V Borovjagin; Peter Timashev; Massimo Cristofanili; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

5.  Double-blind, randomized, placebo-controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of TAK-683, an investigational metastin analogue in healthy men.

Authors:  Graham Scott; Irfan Ahmad; Katy Howard; David MacLean; Cristina Oliva; Steve Warrington; Darren Wilbraham; Paul Worthington
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

6.  KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study.

Authors:  Katharina Schmid; Xiaowei Wang; Andrea Haitel; Wolfang Sieghart; Markus Peck-Radosavljevic; Martin Bodingbauer; Susanne Rasoul-Rockenschaub; Fritz Wrba
Journal:  Virchows Arch       Date:  2007-02       Impact factor: 4.064

7.  Metastin is not involved in metastatic potential of non-small cell lung cancer.

Authors:  Eleni M Karapanagiotou; Kalliopi D Dilana; Ioannis Gkiozos; Ioannis Gratsias; Sotirios Tsimpoukis; Aris Polyzos; Kostas N Syrigos
Journal:  Med Oncol       Date:  2010-03-06       Impact factor: 3.064

8.  Q36R polymorphism of KiSS-1 gene in Brazilian head and neck cancer patients.

Authors:  Mariângela Torreglosa Ruiz; Ana Lívia Silva Galbiatti; Erika Cristina Pavarino; José Victor Maniglia; Eny Maria Goloni-Bertollo
Journal:  Mol Biol Rep       Date:  2012-01-01       Impact factor: 2.316

9.  KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors.

Authors:  Marianna Yaron; Ulrich Renner; Suzan Gilad; Günter K Stalla; Naftali Stern; Yona Greenman
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

10.  Metastin has potential as a suitable biomarker and novel effective therapy for cancer metastasis (Review).

Authors:  Sunao Shoji; Xian Yang Tang; Haruhiro Sato; Yukio Usui; Toyoaki Uchida; Toshiro Terachi
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.